Horse Melanoma: Skin Cancer in Grey Horses and Welfare Management

Melanoma is extremely common in grey horses, affecting the vast majority by old age. Managing this progressive disease requires careful monitoring and timely treatment decisions.

Key Facts

An estimated 70-80% of grey horses over 15 years of age develop melanoma — the grey gene that depigments the coat is strongly linked to melanoma development.
Melanomas in horses are most commonly found under the tail, around the anus and vulva, and on the neck and parotid gland.
Unlike melanoma in humans, equine melanoma is usually slow-growing and often benign — but can become malignant and infiltrate internal organs.
Signs of concern include rapid growth, ulceration, multiple coalescing masses, and signs of internal involvement such as difficulty defecating.
Treatment options include surgical removal (for accessible individual tumors), immunotherapy (cisplatin or BCG injections), and cimetidine (an H2 blocker with anti-tumor effects).
Regular monitoring is essential — the transition from benign to malignant behavior can be gradual and easily missed.
Internal melanomas affecting the rectum, spinal cord, or lung cause significant pain and have a poor prognosis.

Welfare Considerations

Most grey horses with melanoma live comfortably for years with appropriate monitoring and management. The welfare risks arise when tumors become large enough to interfere with defecation, movement, or vision, or when malignant transformation leads to rapid growth and systemic spread. Perianal tumors that obstruct the rectum cause significant pain and inability to defecate — a welfare emergency requiring prompt intervention. Owners of grey horses should establish a baseline assessment of melanoma burden in middle age and monitor for change. Veterinary assessment at any sign of rapid growth, ulceration, or behavioral change is essential. Decisions about treatment versus palliative care versus euthanasia should be made before tumors compromise quality of life to a severe degree.

What You Can Do

Establish a baseline melanoma assessment for your grey horse by age 10-12 and record tumor locations and sizes annually.
Monitor for rapid growth, ulceration, or behavioral signs of pain — these indicate the need for prompt veterinary evaluation.
Discuss treatment options with your vet for accessible, growing tumors — early intervention gives better outcomes.
Check perianal melanomas regularly for any signs of rectal interference — obstruction is a welfare emergency.
Consider cimetidine as a low-risk adjunct treatment for horses with multiple small melanomas under veterinary guidance.
Plan proactively for end-of-life decisions — horses with severe, infiltrating melanoma may reach a welfare endpoint before showing obvious distress.